During this National Emergency the Diversion Control Division will continue to work with its Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.
On March 16, 2020, the DEA published a COVID-19 Information Page on the Diversion Control Division Website. This page contains important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information. This site will be updated frequently as new information and guidance is issued. Please check back frequently for further information.
Please continue to direct all policy questions concerning COVID-19 to the Policy email box at Natural.Disaster@usdoj.gov
Latest Information on the Coronoavirus (COVID-19) from the CDC and NH DHHS:
Portable Document Format (.pdf). Visit nh.gov for a list of free .pdf readers for a variety of operating systems.
Office of Professional Licensure and Certification
7 Eagle Square | Concord, NH 03301
Main Telephone: (603) 271-2152